These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 3886765)
1. The copper-controlled diet: current aspects of dietary copper restriction in management of copper metabolism disorders. Smithgall JM J Am Diet Assoc; 1985 May; 85(5):609-10. PubMed ID: 3886765 [No Abstract] [Full Text] [Related]
2. A copper for your thoughts. Coates RA J Insur Med; 2012; 43(2):112-5. PubMed ID: 22876415 [No Abstract] [Full Text] [Related]
3. [Metabolism of copper and its disorders]. Hauftová D Cas Lek Cesk; 1975 Mar; 114(10-11):341-5. PubMed ID: 1139583 [No Abstract] [Full Text] [Related]
5. [From gene to disease; Wilson disease: copper storage due to mutations in ATP7B]. Hoogenraad TU Ned Tijdschr Geneeskd; 2003 Jul; 147(28):1386-7. PubMed ID: 12892020 [No Abstract] [Full Text] [Related]
6. Zinc treatment for symptomatic Wilson disease: moving forward by looking back. Schilsky M Hepatology; 2009 Nov; 50(5):1341-3. PubMed ID: 19877301 [No Abstract] [Full Text] [Related]
7. Treatment of Wilson's disease (hepatolenticular degeneration) with penicillamine and low-copper diet. Goldstein NP; Tauxe WN; McCall JT; Gross JB; Randall RV Trans Am Neurol Assoc; 1969; 94():34-7. PubMed ID: 5374484 [No Abstract] [Full Text] [Related]
11. [Clinical character and therapeutic effect of late-onset Wilson disease]. Zhang Y; Yang X; Tang X; Luo H; Lei J Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Jan; 34(1):40-4. PubMed ID: 19197125 [TBL] [Abstract][Full Text] [Related]
12. [Management of hepatocerebral degeneration]. Fouquet H; Broser F Med Klin; 1977 Dec; 72(50):2174-7. PubMed ID: 593201 [No Abstract] [Full Text] [Related]
14. Effect of D-penicillamine on liver fibrosis and inflammation in Wilson disease. Kazemi K; Geramizadeh B; Nikeghbalian S; Salahi H; Bahador A; Reza Nejatollahi SM; Dehghani SM; Dehghani M; Kakaei F; Malek-Hosseini SA Exp Clin Transplant; 2008 Dec; 6(4):261-3. PubMed ID: 19338486 [TBL] [Abstract][Full Text] [Related]
15. Penicillamine-induced normalization of clinical signs, and liver morphology and histochemistry in a case of Wilson's disease. Falkmer S; Samuelson G; Sjölin S Pediatrics; 1970 Feb; 45(2):260-8. PubMed ID: 5413388 [No Abstract] [Full Text] [Related]
16. Metabolic studies in Wilson's disease. Evaluation of efficacy of chelation therapy in respect to copper balance. Strickland GT; Blackwell RQ; Watten RH Am J Med; 1971 Jul; 51(1):31-40. PubMed ID: 5570318 [No Abstract] [Full Text] [Related]
17. Copper chelation in patients with Wilson's disease. A comparison of penicillamine and triethylene tetramine dihydrochloride. Walshe JM Q J Med; 1973 Jul; 42(167):441-52. PubMed ID: 4728043 [No Abstract] [Full Text] [Related]
18. [Wilson's disease and secondary copper hemochromatoses in hematological practice]. Vorob'ev AI; Lukina EA; Sysoeva EP; Levina AA; Solov'eva TI Ter Arkh; 2004; 76(7):55-9. PubMed ID: 15379129 [TBL] [Abstract][Full Text] [Related]
19. The story of penicillamine: a difficult birth. Walshe JM Mov Disord; 2003 Aug; 18(8):853-9. PubMed ID: 12889074 [No Abstract] [Full Text] [Related]
20. [Therapy of Wilson disease]. Smolarek C; Stremmel W Z Gastroenterol; 1999 Apr; 37(4):293-300. PubMed ID: 10378366 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]